drugset / Trial / NCT06358820

Exploring the Effectiveness and Safety of Amino Acid Peritoneal Dialysis Solution

NCT06358820 ↗

Phase 4 Completed 149 enrolled The People's Hospital of Gaozhou
NaSingle-groupOpen-labelSupportive care

Summary

This study adopts a multicenter, open, prospective, and self controlled study design, in which each participant serves as their own control before and after receiving amino acid peritoneal dialysis solution treatment to compare changes in their nutritional status. Each subject received treatment with 1 bag of amino acid peritoneal dialysis per day and 2-4 bags of glucose peritoneal dialysis solution per day for 6 months (the amount of glucose peritoneal dialysis solution used was determined based on the treatment plan selected by the patient during the screening period when they entered the study).Before treatment and during the 3rd and 6th months of treatment, subjects were evaluated for various efficacy and safety indicators, and any adverse or serious adverse events were recorded.

Timeline

Start
2023-12-03
Primary completion
2025-01-07
Completion
2025-01-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Amino acid peritoneal dialysis solution Unknown — Other

Indications

No indication recorded.